Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment

被引：4
|
作者：
Koirala, Mahesh [1 ]
DiPaola, Mario [1 ]
机构：
[1] Therabene Inc, Norwood, MA 02062 USA
来源：
BIOMEDICINES | 2024年 / 12卷 / 08期
关键词：
cancer drug resistance; targeted protein degradation; immunotherapy combinations; precision medicine; novel drug delivery systems; PROTACs; SNIPERs; combination therapies; CELL LUNG-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; MULTIDRUG-RESISTANCE; BREAST-CANCER; DRUG-RESISTANCE; MOLECULAR-MECHANISMS; ACQUIRED-RESISTANCE; ESTROGEN-RECEPTOR; GENE-EXPRESSION; P-GLYCOPROTEIN;
D O I：
10.3390/biomedicines12081801
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Resistance to cancer drugs is a complex phenomenon that poses a significant challenge in the treatment of various malignancies. This review comprehensively explores cancer resistance mechanisms and discusses emerging strategies and modalities to overcome this obstacle. Many factors contribute to cancer resistance, including genetic mutations, activation of alternative signaling pathways, and alterations in the tumor microenvironment. Innovative approaches, such as targeted protein degradation, immunotherapy combinations, precision medicine, and novel drug delivery systems, hold promise for improving treatment outcomes. Understanding the intricacies of cancer resistance and leveraging innovative modalities are essential for advancing cancer therapy.
引用
收藏
页数：19
相关论文
共 50 条
  • [21] Strategies for Overcoming EGFR Resistance in the Treatment of Advanced-Stage NSCLC
    Lovly, Christine M.
    Horn, Leora
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (04) : 516 - 526
  • [22] Strategies for Overcoming EGFR Resistance in the Treatment of Advanced-Stage NSCLC
    Christine M. Lovly
    Leora Horn
    Current Treatment Options in Oncology, 2012, 13 : 516 - 526
  • [23] Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
    Luo, Dingtian
    Zhou, Jing
    Ruan, Shuiliang
    Zhang, Binzhong
    Zhu, Huali
    Que, Yangming
    Ying, Shijie
    Li, Xiaowen
    Hu, Yuanmin
    Song, Zhengwei
    CELL DEATH & DISEASE, 2025, 16 (01):
  • [24] Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
    Yoo, Hyeonji
    Kim, Yeonjin
    Kim, Jinseong
    Cho, Hanhee
    Kim, Kwangmeyung
    MOLECULES, 2024, 29 (17):
  • [25] Current strategies in overcoming resistance of cancer cells to apaptosis melanoma as a model
    Hersey, Peter
    Zhuang, L.
    Zhang, X. D.
    INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 251, 2006, 251 : 131 - 158
  • [26] Pharmacological strategies for overcoming multidrug resistance
    Nobili, S.
    Landini, I.
    Giglioni, B.
    Mini, E.
    CURRENT DRUG TARGETS, 2006, 7 (07) : 861 - 879
  • [27] Reporting as resistance: Strategies for overcoming reporting
    Hailparn D.F.
    Hailparn M.
    Journal of Contemporary Psychotherapy, 1999, 29 (2) : 155 - 165
  • [28] Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
    Liu, Xi
    Xu, Jimin
    Zhou, Jia
    Shen, Qiang
    GENES & DISEASES, 2021, 8 (04) : 448 - 462
  • [29] Bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder cancer: Development of resistance to BCG and strategies for overcoming resistance to BCG (Review)
    Mizutani, Y
    Yoshida, O
    Bonavida, B
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (01) : 79 - 86
  • [30] Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders
    Muthu, M. S.
    Singh, S.
    NANOMEDICINE, 2009, 4 (01) : 105 - 118
12345